Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus doxycycline for hidradenitis suppurativa
2020-005271-12Phase 3Completed
- Sponsor
- Erasmus MC
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin in hidradenitis suppurativa (HS) (2 arms), sponsored by Erasmus MC. Primary endpoint: International Hidradenitis Suppurativa Severity Score System (IHS4). Started Mar 2021; status: completed.
02
Drugs
metformin
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2020-005271-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005271-12.